Cargando…

Impact of glycemic control in diabetes mellitus on management of COVID-19 infection

BACKGROUND: Diabetes mellitus may be associated with increased severity and enhanced mortality in COVID-19 infections. The present study was undertaken to evaluate the clinical presentation, laboratory parameters, radiological imaging, management, and outcome of COVID-19 infection in patients of dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandari, Sudhir, Rankawat, Govind, Singh, Ajeet, Gupta, Vishal, Kakkar, Shivankan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466921/
https://www.ncbi.nlm.nih.gov/pubmed/32905072
http://dx.doi.org/10.1007/s13410-020-00868-7
_version_ 1783577916853977088
author Bhandari, Sudhir
Rankawat, Govind
Singh, Ajeet
Gupta, Vishal
Kakkar, Shivankan
author_facet Bhandari, Sudhir
Rankawat, Govind
Singh, Ajeet
Gupta, Vishal
Kakkar, Shivankan
author_sort Bhandari, Sudhir
collection PubMed
description BACKGROUND: Diabetes mellitus may be associated with increased severity and enhanced mortality in COVID-19 infections. The present study was undertaken to evaluate the clinical presentation, laboratory parameters, radiological imaging, management, and outcome of COVID-19 infection in patients of diabetes mellitus and its association with glycemic control. METHODS: The present study was designed to evaluate the difference between uncontrolled and controlled diabetes for COVID-19 manifestations by enrolling 80 admitted COVID-19 patients. Patients were categorized into two groups, where group 1 had patients with uncontrolled diabetes as indicated by HbA1c > 8 g% and group 2 had patients with controlled diabetes as indicated by HbA1c < 8 g%. Information concerning medical history, clinical manifestations, laboratory findings, radiological imaging, management, and outcome was extracted from medical records for evaluation, interpretation, and association among both the groups. RESULTS: COVID-19 patients with uncontrolled diabetes exhibited a severe symptomatic presentation, excessive uncontrolled inflammatory responses, and hypercoagulable state. Total leukocyte count, neutrophil-lymphocyte ratio, serum levels of IL-6, FDP, and D-dimer were significantly raised (p < 0.05) in case of uncontrolled diabetes as compared with controlled diabetes. Radiological findings detected by chest radiograph and computed tomography chest suggested severe lung involvement in uncontrolled diabetes. COVID-19 patients with uncontrolled diabetes required intensive treatment as compared with controlled diabetes group in terms of insulin therapy (p = 0.0226) and non-invasive ventilation (p = 0.0292). Patients with uncontrolled diabetes had higher mortality (p = 0.0375) and required prolonged hospitalization (p = 0.0479) as compared with controlled diabetes group. CONCLUSION: From the current study, it can be concluded that uncontrolled diabetic condition might be a risk factor for severity and morbidity of COVID-19 patients. Uncontrolled diabetes mellitus might be responsible for an overall higher susceptibility for COVID-19 infection and severity in terms of symptomatic presentation, inflammatory storm, rapid pulmonary invasion, requirement of more intensive treatment, and a poor outcome.
format Online
Article
Text
id pubmed-7466921
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-74669212020-09-02 Impact of glycemic control in diabetes mellitus on management of COVID-19 infection Bhandari, Sudhir Rankawat, Govind Singh, Ajeet Gupta, Vishal Kakkar, Shivankan Int J Diabetes Dev Ctries Original Article BACKGROUND: Diabetes mellitus may be associated with increased severity and enhanced mortality in COVID-19 infections. The present study was undertaken to evaluate the clinical presentation, laboratory parameters, radiological imaging, management, and outcome of COVID-19 infection in patients of diabetes mellitus and its association with glycemic control. METHODS: The present study was designed to evaluate the difference between uncontrolled and controlled diabetes for COVID-19 manifestations by enrolling 80 admitted COVID-19 patients. Patients were categorized into two groups, where group 1 had patients with uncontrolled diabetes as indicated by HbA1c > 8 g% and group 2 had patients with controlled diabetes as indicated by HbA1c < 8 g%. Information concerning medical history, clinical manifestations, laboratory findings, radiological imaging, management, and outcome was extracted from medical records for evaluation, interpretation, and association among both the groups. RESULTS: COVID-19 patients with uncontrolled diabetes exhibited a severe symptomatic presentation, excessive uncontrolled inflammatory responses, and hypercoagulable state. Total leukocyte count, neutrophil-lymphocyte ratio, serum levels of IL-6, FDP, and D-dimer were significantly raised (p < 0.05) in case of uncontrolled diabetes as compared with controlled diabetes. Radiological findings detected by chest radiograph and computed tomography chest suggested severe lung involvement in uncontrolled diabetes. COVID-19 patients with uncontrolled diabetes required intensive treatment as compared with controlled diabetes group in terms of insulin therapy (p = 0.0226) and non-invasive ventilation (p = 0.0292). Patients with uncontrolled diabetes had higher mortality (p = 0.0375) and required prolonged hospitalization (p = 0.0479) as compared with controlled diabetes group. CONCLUSION: From the current study, it can be concluded that uncontrolled diabetic condition might be a risk factor for severity and morbidity of COVID-19 patients. Uncontrolled diabetes mellitus might be responsible for an overall higher susceptibility for COVID-19 infection and severity in terms of symptomatic presentation, inflammatory storm, rapid pulmonary invasion, requirement of more intensive treatment, and a poor outcome. Springer India 2020-09-02 2020-09 /pmc/articles/PMC7466921/ /pubmed/32905072 http://dx.doi.org/10.1007/s13410-020-00868-7 Text en © Research Society for Study of Diabetes in India 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Bhandari, Sudhir
Rankawat, Govind
Singh, Ajeet
Gupta, Vishal
Kakkar, Shivankan
Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
title Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
title_full Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
title_fullStr Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
title_full_unstemmed Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
title_short Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
title_sort impact of glycemic control in diabetes mellitus on management of covid-19 infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466921/
https://www.ncbi.nlm.nih.gov/pubmed/32905072
http://dx.doi.org/10.1007/s13410-020-00868-7
work_keys_str_mv AT bhandarisudhir impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection
AT rankawatgovind impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection
AT singhajeet impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection
AT guptavishal impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection
AT kakkarshivankan impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection